These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2207327)

  • 21. Conversion of the active to latent plasminogen activator inhibitor from human endothelial cells.
    Levin EG; Santell L
    Blood; 1987 Oct; 70(4):1090-8. PubMed ID: 3498518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetic analysis of the interaction between type 1 plasminogen activator inhibitor and vitronectin and evidence that the bovine inhibitor binds to a thrombin-derived amino-terminal fragment of bovine vitronectin.
    Seiffert D; Loskutoff DJ
    Biochim Biophys Acta; 1991 May; 1078(1):23-30. PubMed ID: 1710930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic structural and functional relationships in recombinant plasminogen activator inhibitor-1 (rPAI-1).
    Vaughan DE; Declerck PJ; Reilly TM; Park K; Collen D; Fasman GD
    Biochim Biophys Acta; 1993 Oct; 1202(2):221-9. PubMed ID: 8399383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A truncated plasminogen activator inhibitor-1 protein induces and inhibits angiostatin (kringles 1-3), a plasminogen cleavage product.
    Mulligan-Kehoe MJ; Wagner R; Wieland C; Powell R
    J Biol Chem; 2001 Mar; 276(11):8588-96. PubMed ID: 11113116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of plasminogen activator inhibitor-1 in promoting fibrin deposition in rabbits infused with ancrod or thrombin.
    Krishnamurti C; Bolan C; Colleton CA; Reilly TM; Alving BM
    Blood; 1993 Dec; 82(12):3631-6. PubMed ID: 8260701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of determinants involved in binding of tissue-type plasminogen activator-plasminogen activator inhibitor type 1 complexes to HepG2 cells.
    Morton PA; Owensby DA; Wun TC; Billadello JJ; Schwartz AL
    J Biol Chem; 1990 Aug; 265(24):14093-9. PubMed ID: 2167306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and partial characterization by chemical cross-linking of a binding protein for tissue-type plasminogen activator (t-PA) on rat hepatoma cells. A plasminogen activator inhibitor type 1-independent t-PA receptor.
    Bu G; Morton PA; Schwartz AL
    J Biol Chem; 1992 Aug; 267(22):15595-602. PubMed ID: 1322401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions between tissue-type plasminogen activator and extracellular matrix-associated plasminogen activator inhibitor type 1 in the human hepatoma cell line HepG2.
    Owensby DA; Morton PA; Schwartz AL
    J Biol Chem; 1989 Oct; 264(30):18180-7. PubMed ID: 2553701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of type 1 plasminogen activator inhibitor to the extracellular matrix of cultured bovine endothelial cells.
    Mimuro J; Loskutoff DJ
    J Biol Chem; 1989 Mar; 264(9):5058-63. PubMed ID: 2494180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.
    Leiper K; Croll A; Booth NA; Moore NR; Sinclair T; Bennett B
    J Clin Pathol; 1994 Mar; 47(3):214-7. PubMed ID: 8163691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of plasminogen activator inhibitor by products released from platelets.
    Fujii S; Sobel BE
    Circulation; 1990 Oct; 82(4):1485-93. PubMed ID: 2401077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator.
    Hekman CM; Loskutoff DJ
    Arch Biochem Biophys; 1988 Apr; 262(1):199-210. PubMed ID: 3128176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasminogen activator inhibitor-1 suppresses endogenous fibrinolysis in a canine model of pulmonary embolism.
    Reilly CF; Fujita T; Hutzelmann JE; Mayer EJ; Shebuski RJ
    Circulation; 1991 Jul; 84(1):287-92. PubMed ID: 1905594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accelerated thrombus lysis in the blood of plasminogen activator inhibitor deficient mice is inhibited by PAI-1 with a very long half-life.
    Jankun J; Aleem AM; Struniawski R; Lysiak-Szydłowska W; Selman SH; Skrzypczak-Jankun E
    Pharmacol Rep; 2009; 61(4):673-80. PubMed ID: 19815949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiangiogenic activity of rPAI-1(23) promotes vasa vasorum regression in hypercholesterolemic mice through a plasmin-dependent mechanism.
    Mollmark J; Ravi S; Sun B; Shipman S; Buitendijk M; Simons M; Mulligan-Kehoe MJ
    Circ Res; 2011 Jun; 108(12):1419-28. PubMed ID: 21546607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular forms of plasminogen activator inhibitor-1 (PAI-1) and tissue-type plasminogen activator (t-PA) in human plasma.
    Alessi MC; Juhan-Vague I; Declerck PJ; Collen D
    Thromb Res; 1991 May; 62(4):275-85. PubMed ID: 1907771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation.
    Kruithof EK; Nicolosa G; Bachmann F
    Blood; 1987 Nov; 70(5):1645-53. PubMed ID: 3117137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoaffinity purification of HTC rat hepatoma cell plasminogen activator-inhibitor-1.
    Zeheb R; Rafferty UM; Rodriguez MA; Andreasen P; Gelehrter TD
    Thromb Haemost; 1987 Dec; 58(4):1017-23. PubMed ID: 3127913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Forskolin down-regulates type-1 plasminogen activator inhibitor and tissue-type plasminogen activator and their mRNAs in human fibrosarcoma cells.
    Georg B; Riccio A; Andreasen P
    Mol Cell Endocrinol; 1990 Aug; 72(2):103-10. PubMed ID: 1704320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis.
    Björquist P; Ehnebom J; Inghardt T; Hansson L; Lindberg M; Linschoten M; Strömqvist M; Deinum J
    Biochemistry; 1998 Feb; 37(5):1227-34. PubMed ID: 9477948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.